NR1I2 and Abnormal intestine morphology: It has been reported that the use of PXR agonists does not aggravate the ibuprofen-induced intestinal injury, demonstrating that PXR signaling is not a causative factor in ibuprofen-induced enteropathy (Lu et al., 2018).